135 related articles for article (PubMed ID: 7711425)
1. Lecithin-cholesterol acryltransferase activity in patients with coronary artery disease examined by coronary angiography.
Solajić-Bozicević N; Stavljenić-Rukavina A; Sesto M
Clin Investig; 1994 Dec; 72(12):951-6. PubMed ID: 7711425
[TBL] [Abstract][Full Text] [Related]
2. Lecithin:cholesterol acyltransferase activity in patients with acute myocardial infarction and coronary heart disease.
Solajić-Bozicević N; Stavljenić A; Sesto M
Artery; 1991; 18(6):326-40. PubMed ID: 1750805
[TBL] [Abstract][Full Text] [Related]
3. Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden.
Gebhard C; Rhainds D; He G; Rodés-Cabau J; Lavi S; Spence JD; Title L; Kouz S; L'Allier PL; Grégoire J; Ibrahim R; Cossette M; Guertin MC; Beanlands R; Rhéaume E; Tardif JC
Atherosclerosis; 2018 Sep; 276():131-139. PubMed ID: 30059844
[TBL] [Abstract][Full Text] [Related]
4. Plasma high density lipoproteins and coronary artery disease.
Sodhi HS; Lee G; Joye JA; Clifford CK; Kudchodkar BJ; Terai Y; Shaw I; Mason DT
Adv Myocardiol; 1980; 2():513-25. PubMed ID: 7423063
[TBL] [Abstract][Full Text] [Related]
5. [LCAT (lecithin:cholesterol acyltransferase)].
Kinoshita M; Teramoto T
Rinsho Byori; 2001 Nov; Suppl 116():125-30. PubMed ID: 11797372
[TBL] [Abstract][Full Text] [Related]
6. Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness.
Dullaart RP; Perton F; Sluiter WJ; de Vries R; van Tol A
J Clin Endocrinol Metab; 2008 Dec; 93(12):4860-6. PubMed ID: 18782872
[TBL] [Abstract][Full Text] [Related]
7. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
[TBL] [Abstract][Full Text] [Related]
8. Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study.
Yokoyama K; Tani S; Matsuo R; Matsumoto N
BMC Cardiovasc Disord; 2018 Dec; 18(1):224. PubMed ID: 30518338
[TBL] [Abstract][Full Text] [Related]
9. Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study.
Tani S; Takahashi A; Nagao K; Hirayama A
Heart Vessels; 2016 Jun; 31(6):831-40. PubMed ID: 25894629
[TBL] [Abstract][Full Text] [Related]
10. Investigation of relationship between lecithin:cholesterol acyltransferase activity and coronary atheroma, diagnosed by selective coronary angiography.
Bernstein M; Bernstein V
Scand J Clin Lab Invest Suppl; 1978; 150():124-8. PubMed ID: 746339
[TBL] [Abstract][Full Text] [Related]
11. Lecithin:cholesterol acyl transfer in plasma of normal persons in relation to lipid and lipoprotein concentration.
Wallentin L; Vikrot O
Scand J Clin Lab Invest; 1975 Nov; 35(7):669-76. PubMed ID: 174186
[TBL] [Abstract][Full Text] [Related]
12. Lecithin: cholesterol acyltransferase and lysolecithin in coronary atherosclerosis.
Wells IC; Peitzmeier G; Vincent JK
Exp Mol Pathol; 1986 Dec; 45(3):303-10. PubMed ID: 3466803
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma lecithin:cholesterol acyltransferase activity and plasma triglyceride concentration in non-pregnant and pregnant Brazilian women.
Gillett MP; Silva TB
Scand J Clin Lab Invest Suppl; 1978; 150():118-23. PubMed ID: 218270
[TBL] [Abstract][Full Text] [Related]
14. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
[TBL] [Abstract][Full Text] [Related]
15. Plasma lecithin-cholesterol acyltransferase activity and cholesterol and phospholipid levels in premature newborn infants.
Jain SK; Diaz JJ
Biochim Biophys Acta; 1991 Nov; 1086(2):225-9. PubMed ID: 1932105
[TBL] [Abstract][Full Text] [Related]
16. [Esterifying activity of the plasma in patients with ischemic heart disease].
Ozerova IN; Gerasimova EN; Maĭ FT; Kurdanov KhA
Vopr Med Khim; 1984; 30(5):118-23. PubMed ID: 6528515
[TBL] [Abstract][Full Text] [Related]
17. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
Dullaart RP; Perton F; van der Klauw MM; Hillege HL; Sluiter WJ;
Atherosclerosis; 2010 Feb; 208(2):537-42. PubMed ID: 19698944
[TBL] [Abstract][Full Text] [Related]
18. High density lipoprotein cholesterol and triglycerides as markers of angiographically assessed coronary artery disease.
Nikkilä M; Koivula T; Niemelä K; Sisto T
Br Heart J; 1990 Feb; 63(2):78-81. PubMed ID: 2317412
[TBL] [Abstract][Full Text] [Related]
19. Dietary fats and lecithin-cholesterol acyltransferase activity in healthy humans.
Baudet MF; Jacotot B
Ann Nutr Metab; 1988; 32(5-6):352-9. PubMed ID: 3254691
[TBL] [Abstract][Full Text] [Related]
20. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
